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Background/aim: Leishmaniasis is a disease group carried by Phlebotomus and Lutzomyia sand flies infected with Leishmania and is
mostly observed in rural areas. In this study, using high-resolution melting analysis (HRMA), we aim to identify the active types of
leishmaniasis, which are inadequately identified by classical methods.
Materials and methods: Samples of 85 patients were examined in the study. Six of the patients were suspected of having visceral
leishmaniasis (VL) and 79 cutaneous leishmaniasis (CL). The slides prepared from the samples were stained with Giemsa stain and
examined under a light microscope. The results were compared with those determined in real-time PCR. When the real-time PCR result
was positive for Leishmania, we determined the type by HRMA.
Results: Among 85 Leishmania amastigote samples, 28 (32.9%) of them were detected and accepted as positive by microscopic
examination. On the other hand, 25 (29.4%) of the 85 samples were found as positive using real-time PCR. In addition, when 25
Leishmania-positive samples were examined by HRMA, the results showed that 21 (84%) were L. tropica, 3 (12%) were L. major, and 1
(4%) was L. infantum.
Conclusion: Based on our findings, we conclude that using real-time PCR and HRMA is useful in determining the cause of the disease
in leishmaniasis.
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1. Introduction
Leishmaniasis appears when female sand flies
(Phlebotomus species in the Old World, Lutzomyia species
in the New World), which have Leishmania parasites as
compulsory agents in the cell, suck blood from humans.
According to the World Health Organization (WHO),
Leishmania is one of the seven most important tropical
diseases, and it is endemic in 98 countries (1,2). In clinical
terms, Leishmania can be separated into two subclasses:
cutaneous leishmaniasis (CL), which heals by leaving a
trace after causing deformations, and visceral leishmaniasis
(VL), which may be fatal when not treated. Neither form is
not dependent on certain Leishmania types (2,3).
The conventional opinion is that the causes of VL are
L. infantum and L. donovani and that the causes of CL are
L. tropica and L. major (4,5). However, in recent years, we
have also seen cases in which L. tropica causes VL and
L. infantum causes CL. Also, new Leishmania types have
been detected among the nearly 4 million immigrants
who fled from Syria during the recent internal conflicts

and found refuge in Turkey (6). In Turkey, leishmaniasis
is seen clinically in two forms: CL and VL. In Turkey,
anthroponotic CL, in which L. tropica is the active agent,
has been reported since 1833, sometimes as epidemics.
Half of the cases were reported in the province of Şanlıurfa.
Although VL (in which L. infantum is the active agent) is
mostly seen in the Aegean and Mediterranean regions,
there are cases reported from nearly all regions of Turkey
(7,8).
In addition, with increased travel opportunities and
human relations, developing technologies, and changes
in climatic, socioeconomic, and sociopolitical conditions,
new drug-resistant Leishmania types have developed
(6,9,10).
The prognoses and severity of the disease vary and
depend on the immune response of the patient and on the
types of the Leishmania, and even on its parasite strains. To
avoid infection and plan proper treatment, it is important
that the disease-causing parasite be defined in a fast and
accurate manner. In this respect, various protocols have
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been optimized and developed to discriminate between
the different Leishmania types, and the efficiency of the
most proper medication is targeted (11).
Various molecular methods have been developed to
detect the Leishmania parasites in clinical samples. One
such method is high-resolution melting analysis (HRMA)
(12,13). HRMA is a simple and extremely sensitive method
realized in the existing real-time PCR systems. It is costeffective and simple to use when compared with the other
sequencing methods for genotyping (14,15).
Here, using a molecular approach, we determine the
types of Leishmania that are difficult to detect by classical
methods. Also, we use the HRMA method to determine
the various Leishmania types in Turkey.
2. Materials and methods
2.1. Study area
The study was conducted in İstanbul, located in the western
part of Turkey, and in Şanlıurfa, which has a border with
Syria and is located in an endemic area, the Southeast
Anatolia region of Turkey.
2.2. Sample collection
In this present study, which was conducted between
November 2015 and March 2017, bone marrow samples
were taken from six patients who were prediagnosed
with VL. The samples were sent to the İstanbul University
Cerrahpaşa Faculty of Medicine’s medical microbiology
department laboratory for diagnosis. The serous fluid
samples of the skin lesions of 14 patients who were
suspected of CL were also used in the study. In addition,
skin exudate materials taken from 65 patients who were
prediagnosed with CL were also used in the present study.
These patients had applied to the Republic of Turkey
Ministry of Health, Şanlıurfa Oriental Sore Diagnosis and
Treatment Center. The protocol of the study was approved
by the İstanbul University Cerrahpaşa Faculty of Medicine’s
Clinical Research Ethics Board (No: 83045809/604.01/02313761).
2.3. Direct examination (light microscopy)
The samples were spread onto glass slides and were left
to dry in open air. Then the slides that were fixed with
methanol were stained with Giemsa stain. All the slides
were subjected to main examination under a 100× oilimmersion objective. For the purpose of increasing the
sensitivity, both slides were examined by two different
researchers experienced in the field of parasitology. The
slides on which the amastigote form was detected were
defined as positive, and those on which the amastigote
form was not detected were defined as negative.
2.4. DNA extraction, PCR assays, HRMA, and sequencing
To perform DNA extraction from direct samples taken
from patients, the High Pure PCR Template Preparation
Kit (Roche Diagnostics, Mannheim, Germany) was

used according to the instructions of the manufacturing
company. When the process was completed, 100 µL
of DNA was obtained and kept at –20 °C until the PCR
process was completed.
The DNA samples were reproduced using two specific
primers (CJ7SLF and QRT7SLR) that targeted the 7SLRNA gene areas (13). The primer series and protocols used
in the amplification are given in the Table.
Real-time PCR amplification and HRMA were
performed in the LightCycler Nano System (Roche
Diagnostics) with LightCycler 480 High Resolution
Melting Master (Roche Applied Science) by optimization
under the cycle conditions given in the Table. After 40
cycles, the temperature was increased at a rate of 0.02 °C
per second from 65 °C to 95 °C, and the melting curves
were obtained according to the measured fluorescent
values. The melting curves were analyzed using the PCR
software and the HRMA profiles were defined.
All of the isolates that were determined as positive
in real-time PCR with HRMA and that were included in
groups were subjected to series analysis. A T100 Thermal
Cycler (Bio-Rad, France) was used to perform the PCRs.
In the present study, the primers that encoded the ITS1
(internal transcribed spacer 1) gene area of the Leishmania
types were used. The PCR process in which we used the
LITSR and L5.8S primers were performed under the
thermal cycle and conditions given in the Table.
The base sequencing analysis was performed with the
MegaBACE 1000 automatic base sequencing instrument.
The values were read in light of the instructions of the
manufacturer company and the chromatogram data were
received. The chromatogram files were converted into
FASTA files and were compared manually by using the
Sequencher 4.10.1, MEGA 4.1, and FinchTV sequence
programs. The gene series that were obtained were
analyzed by comparing them with the other Leishmania
types recorded by using the BLAST program from the
National Center for Biotechnology Information (NCBI)
website (https://blast.ncbi.nlm.nih.gov/Blast.cgi).
2.5. Statistical analysis
The frequency, percentage, average, and mean values were
computed for descriptive statistics. The statistical analysis
of the results was performed using the IBM SPSS 21.0
(IBM Corp., Armonk, NY, USA).
3. Results
3.1. Microscopic examination
By microscopic examination of Giemsa-stained slides,
in 27 (34.2%) of 79 skin lesion samples Leishmania
amastigotes were detected; hence, these were considered
as positive samples. Among Giemsa-stained slides of
the bone marrow samples, only one (16.7%) sample was
defined as positive.
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Target

7SL
RNA

ITS1

PCR-based
method

PCR-HRMA

PCR
sequencing

5’-TGA TAC CAC TTA TCG CAC TT-3’

1.5

95 °C for 10 min, 95 °C for 20 s,
56 °C for 40 s, 68 °C for 1 min,
68 °C for 5 min (30 cycles)

5’-CTG GAT CAT TTT CCG ATG-3’

5’-CGG TTC CCT CGC TTC AAC-3’

95 °C for 10 min, 95 °C for 10 s,
59 °C for 25 s, 72 °C for 15 s, 95 °C
2
for 1 min, 40 °C for 1 min,
65 °C for 1 s, 95 °C for 1 s (40 cycles)

5’-ACG TGG ACC AGC GAG GGT-3’

1

0.2

5

0.2

0.25

0.25

3

5

MgCl2 dNTP Primer Taq DNA
DNA
(mM) (mM) (µM) polymerase (µL) (µL)

PCR conditions
Amplification conditions

Primer sequence

Table. The primer series and PCR protocols of the PCR methods.

SİREKBASAN and POLAT / Turk J Med Sci

SİREKBASAN and POLAT / Turk J Med Sci
3.2. Leishmania species identification by PCR-HRMA
According to the real-time PCR, positive results were
found in 25 (31.6%) of 79 CL cases. There was no positive
result by real-time PCR in samples from VL-suspected
cases.
Our HRMA findings are shown in the Figure. The
HRMA curves were divided into three groups, and of the
25 Leishmania-positive samples, 21 were L. tropica, three
were L. major, and one was L. infantum. Those isolates
positive for Leishmania were divided into groups (L.
major, L. infantum, and L. tropica) and a series of analyses
were performed.
When we compared the sequences obtained from our
samples with Leishmania types recorded in the NCBI
GenBank, the L. tropica samples revealed 93%–97%
similarity, L. major 96%–97% similarity, and L. infantum
96% similarity.
4. Discussion
When we consider the data on leishmaniasis since 2000
in Turkey, the mean annual number of VL cases is 27, and
the total number of the CL cases is 2020 (14). According to
the data released by the WHO in 2014, more than 1 billion
people (556 million VL, and 399 million CL) are at risk
of leishmaniasis. In addition, 44% of Turkey’s population
faces the risk of being infected with CL and 9% of the
population faces the risk of being infected with VL (16,17).
Many laboratory methods are used to diagnose
leishmaniasis. It has been reported that molecular methods
are more sensitive compared to traditional microscopy
and culture methods (18–20). In our study, we detected
28 positive cases by light microscopy and 25 positive cases
by real-time PCR. The samples detected in at least any of
the two diagnostic methods were considered as positive.
In this case, 27 (34.2%) of 79 patients were diagnosed with

CL and 1 (16.7%) of the 6 patients was diagnosed with VL.
Abd El-Salam et al. (21) conducted a study on CL
patients with microscopy, culture, and PCR techniques and
reported positivity rates of 54%, 47%, and 88%, respectively.
These authors claimed that PCR was more sensitive than
the other methods. Ertabaklar et al. (22) compared the
microscopy, culture, and PCR methods in CL diagnosis.
In this study the authors detected 29 (53%) amastigotes,
34 (62%) promastigotes, and 30 (55%) parasite-specific
amplicons by using direct microscopic examination,
culture, and PCR methods, respectively. These authors
reported that the culture method was the most sensitive
method in diagnosing CL. Rasti et al. (20) conducted a
comparative study and used microscopy, culture, and
molecular methods in 130 cases, reporting positivity rates
of 67%, 56%, and 75%, respectively. They reported that the
most sensitive method was PCR in their study and added
that the sensitivity in diagnosis increased when PCR and
microscopy were used together.
In previous studies, the PCR method has been ranked
first among the methods used in diagnosing leishmaniasis,
whereas here we found that the microscopic examination
method was more sensitive. This might be because of a lack
of proper sampling and the existence of a PCR inhibitor in
the samples. Therefore, we recommend that PCR be used
together with other methods, rather than using it alone,
which will enable the diagnosis of more cases and therefore
will be more useful in diagnosis and follow-up stages of the
disease.
Considering the recent studies carried out in Turkey,
L. infantum and L. major were detected in CL cases and
L. tropica was detected in VL (7,8,23). This might be a
clue that the Leishmania that causes CL and VL seen in
Turkey has started to modify, so it is important to know the
Leishmania parasite types in Turkey, which is located in a

Figure. HRMA results.
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wide geographical area with different climatic conditions.
Due to Turkey’s geographical location, increasing travel
opportunities, and nearly 4 million immigrants who fled to
Turkey from Syria due to civil war in December 2011, there
has been an increase in foreign-originated leishmaniasis
cases in Turkey. Globally, Iran is ranked first as having the
most Leishmania cases, and Turkey is second (24). Hence,
it is important to characterize Leishmania strains at the
molecular level to exhibit the drug resistance or clinical form.
In our study, we detected L. infantum in a CL patient who
did not have a history of VL. In addition, 2 of the 3 L. major
cases with CL occurred in Syrian citizens who came from
Syria to İstanbul, and one belonged to a Turkish citizen who
had a history of travel to Afghanistan. Thus, we considered
the L. major types as being foreign-originated. Similar
cases were also detected in other countries. As an example,
although L. donovani is more commonly associated with
VL, it was reported that L. donovani was detected with CL
in some countries, such as France (25). Thus, we considered
the L. major types to be foreign-originated.
The prognosis and clinical presentation of the disease
vary according to the types of Leishmania, and this results in
difficulties in diagnosis. For this reason, the discrimination
of the Leishmania parasite is important. In genotyping the
Leishmania types, methods such as restriction fragment
length polymorphism (RFLP), multilocus enzyme
electrophoresis (MLEE), and multilocus sequence typing
(MLST) have been used for many years (26,27). The
costs of these methods and long procedures (such as the
interpretation of complex data) are disadvantageous. A

method that enables cost-effective, fast, sensitive, easily
repeatable detection must be employed to overcome these
disadvantages (28).
HRMA is used for genotyping of various bacteria,
fungi, and parasites, and it can be used in defining and
genotyping Leishmania (29–31). It has been reported that
HRMA is 3-fold faster and 5-fold cheaper than RFLP and
MLST analyses. It has also been reported that HRMA has
considerable potential for the determination of Leishmania
types and genetic characterization (32).
In the present study, real-time PCR and HRMA were
used to define the Leishmania types. Three groups of curves
were obtained by HRMA examination of the Leishmaniapositive (real-time PCR) samples. In the HRMA
examination of the 25 Leishmania-positive samples by realtime PCR, 21 (84%) were L. tropica, three (12%) were L.
major, and one (4%) was L. infantum.
In conclusion, leishmaniasis is an important public
health problem in Turkey, as well as many other countries
of the world. Since the prognosis and clinical presentation
of the disease vary according to the type of Leishmania, we
believe that clinicians and researchers must consider the
changing active agent profile for possible precautions in
public healthcare systems. For this reason, we believe that
HRMA and genotyping will be useful in the diagnosis of
Leishmania and to monitor its changing epidemiology.
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